Grupo Moehs.
Referente a nivel mundial
En un mercado de rápido crecimiento y alta competitividad, Grupo Moehs ha progresado convirtiéndose en una de las principales compañías a nivel mundial.
Los factores clave que confirman esta trayectoria son:
Consolidación de una amplia gama de productos con diferentes actividades terapéuticas: desde mucolíticos hasta ß-blocantes.
Ampliación continua de nuestra lista de APIs.
Óptimo equilibrio entre costes y servicios ofrecidos.
Capacidad de comprensión de las necesidades transmitidas por los clientes para trasladarlas a nuestra gama.
Soporte documental y regulatorio.
Lista de Productos
| Nombre producto | Cas nº | Categoría terapéutica | Datos Regulatorios | Farmacopeas | Planta de producción |
|---|---|---|---|---|---|
| CLOPERASTINE FENDIZOATE | 85187-37-7 | CNS Antitussive Antihystaminic | TP | Japanese Pharmacopoeia | |
| EDOXABAN TOSYLATE (**) | 1229194-11-9 | Oral anticoagulant Validation | DMF | ||
| EMPAGLIFLOZIN (**) | 864070-44-0 | Antidiabetic | DMF | ||
| LEVOBUPIVACAINE HCl | 27262-48-2 | Local AnestheticAntiarrhythmic | DMF | ||
| NORADRENALINE TARTRATE | 108341-18-0 | Cardiovascular | TP | USP / Ph. Eur. | |
| REMIMAZOLAM BESYLATE (**) | 308242-62-8 | Sedation General Anesthesia | DMF | ||
| RIMEGEPANT SULFATE (**) | 1374024-48-2 | Acute migraine | DMF | ||
| RIVAROXABAN | 366789-02-8 | Oral anticoagulant | CEP, DMF | Ph. Eur. | |
| SITAGLIPTIN PHOSPHATE | 654671-77-9 | Antidiabetic | DMF | USP / Ph. Eur. | |
| ACEBUTOLOL HCL | 34381-68-5 | Antianginal – Antihypertensive – Antiarrhythmic | CEP, EDMF, USDMF | Ph. Eur. 11, USP-NF-2022, JP 16 | M. CANTABRA & COPRIMA |
| AMANTADINE HCl | 665-66-7 | Antiviral -Antiparkinsonian | CEP, EDMF USDMF | Ph. Eur. 11 USP-NF-2022, JP 16 | M. CATALANA |
| AMANTADINE SULPHATE | 31377-23-8 | Antiviral -Antiparkinsonian | EDMF | DAC 2011 | CANTABRA |
| AMLODIPINE BESILATE | 111470-99-6 | Antianginal – Antihypertensive | CEP, EDMF, USDMF, JDMF, KDMF | Ph. Eur. 11, USP-NF-2022, JP 16 | M. CATALANA |
| ARTICAINE HCI or CARTICAINE HCI | 23964-57-0 | Local Anesthetic- Antiarrhythmic | CEP, EDMF, USDMF | Ph. Eur. 11, USP-NF-2022 | BENECHIM |
| BISOPROLOL FUMARATE | 104344-23-2 | Antihypertensive | CEP, EDMF, USDMF, JDMF, ND | Ph. Eur. 11, USP-NF-2022, JP 16 | M. CATALANA |
| BUPIVACAINE HYDROCHLORIDE | 73360-54-0 | Local Anesthetic-Antiarrhythmic | CEP, EDMF, USDMF, ND | Ph. Eur. 11, USP-NF-2022 | M. CATALANA |
| BUTALBITAL | (1953-33-9) | Hypnotic - Sedative | DMF Type II | USP | CFB |
| CARBOCYSTEINE | 638-23-3 | Mucolytic | CEP, EDMF, JDMF | Ph. Eur. 11, JP 16 | M. CATALANA & M. BCN |
| CARBOCYSTEINE LYSINE SALT | 151756-26-2 | Mucolytic | EDMF | in house | M. BCN |
| CARVEDILOL | 72956-09-3 | Antihypertensive | CEP, EDMF, USDMF, JDMF, KDMF, ND | Ph. Eur. 11, USP-NF-2022 | M. CATALANA & COPRIMA |
| CELIPROLOL HCI | 57470-78-7 | Antianginal- Antihypertensive | CEP, EDMF, JDMF | Ph. Eur. 11 | COPRIMA |
| CHLORALHYDRATE | 302-17-0 | Hypnotic - Sedative | TP | Ph. Eur., USP | CFB |
| CHOLINE FENOFIBRATE | 856676-23-8 | Antihyperlipidemic | USDMF | In house | COPRIMA |
| CINCHOPHEN | 132-60-5 | Analgesic - antipyretic | ASMF (CTD) | Ph. Eur. | CFB |
| DEXMEDETOMIDINE HCL | 145108-58-3 | Sedative | DMF | USP-NF-2022 | NORCHIM & IBERICA |
| DOMIPHEN BROMIDE | 538-71-6 | Disinfectant | TP | BP | CFB |
| DOXAZOSIN MESYLATE | 77883-43-3 | Antihypertensive | CEP | Ph. Eur. | CFB |
| DULOXETINE HCL | 136434-34-9 | Antidepressant | CEP, EDMF, USDMF, KDMF | Ph. Eur. 11, USP-NF-2022 | M. CANTABRA & M. BCN |
| FENOFIBRATE | 49562-28-9 | Antihyperlipidemic | CEP, EDMF, USDMF, ND | Ph. Eur. 11, USP-NF-2022 | COPRIMA |
| LIDOCAINE BASE | 137-58-06 | Local Anesthetic-Antiarrhythmic | CEP, EDMF,JDMF, USDMF | Ph. Eur. 11, USP-NF-2022 | M. CATALANA &. BCN |
| LIDOCAINE HCI | 6108-05-0 | Local Anesthetic-Antiarrhythmic | CEP, EDMF, USDMF, JDMF | Ph. Eur. 11, USP-NF-2022 | M. CATALANA & M. BCN |
| MAGNESIUM LACTAE DIHYDRATE | 18917-93-6 | Magnesium Supplement | EDMF, ND | Ph. Eur. 11 | CANTABRA |
| MEBEVERINE HCl | 2753-45-9 | Antispasmodic | EDMF, ND | Ph. Eur 11, BP 2013 | BENECHIM |
| MEPIVACAINE HYDROCHLORIDE | 1722-62-9 | Local Anesthetic-Antiarrhythmic | CEP, EDMF, USDMF | Ph. Eur. 11, USP-NF-2022, JP 16 | M. CATALANA |
| METHENAMINE HIPPURATE | 5714-73-8 | Antibacterial (urinary) | DMF Type II | USP | CFB |
| METOPROLOL SUCCINATE | 98418-47-4 | Antihypertensive | CEP, EDMF USDMF | Ph. Eur. 11 USP-NF-2022 | CATALANA & BENECHIM |
| METOPROLOL TARTRATE | 56392-17-7 | Antihypertensive | CEP, EDMF USDMF, JDMF | Ph. Eur. 11 USP-NF-2022, JP 16 | M. CATALANA |
| N-ACETYLCYSTEINE | 616-91-1 | Mucolytic | CEP, EDMF, USDMF, ND | Ph. Eur. 11, USP-NF-2022 | M. CATALANA |
| NIFEDIPINE | 21829-25-4 | Antianginal-Antihypertensive | CEP, EDMF, USDMF, JDMF | Ph. Eur. 11, USP-NF-2022, JP 16 | M. CATALANA |
| NIFUROXAZIDE | 965-52-6 | Antidiarrheal | EDMF, ND | Ph. Eur. 11 | COPRIMA |
| NIKETHAMIDE | 59-26-7 | Respiratory analeptic | ASMF (CTD) | Ph. Eur. | CFB |
| PANTOPRAZOLE SODIUM | 164579-32-2 | Antiulcerative | CEP, EDMF, USDMF, ND | Ph. Eur. 11, USP-NF-2022 | M. CANTABRA |
| PENTOBARBITAL | 76-74-4 | Anesthetic - Euthanasia - Hypnotic - Sedative | ASMF (CTD) | Ph. Eur. | CFB |
| PENTOBARBITAL SODIUM | 57-33-0 | Anesthetic - Euthanasia - Hypnotic - Sedative | CEP | Ph. Eur., USP | CFB |
| PHENOBARBITAL | 50-06-6 | Anticonvulsant - Hypnotic - Sedative | CEP | Ph. Eur., USP | CFB |
| PHENOBARBITAL SODIUM | 57-30-7 | Anticonvulsant - Hypnotic - Sedative | - | Ph. Eur., USP | CFB |
| PHENTERMINE HCL | 1197-21-3 | Appetite suppressant | DMF Type II | USP | CFB |
| PICLOXIDINE DIHYDROCHLORIDE | 19803-62-4 | Antiseptic (eye drops) | ASMF (CTD) | Ph. Eur. | CFB |
| PRILOCAINE BASE | 721-50-6 | Local Anesthetic | EDMF, USDMF | Ph. Eur. 11, USP-NF-2022 | BENECHIM |
| PRILOCAINE HCL | 1786-81-8 | Local Anesthetic-Antiarrhythmic | EDMF, USDMF | Ph. Eur. 11, USP-NF-2022 | BENECHIM |
| PYRANTEL EMBONATE | 22204-24-6 | Anthelmintic | EVMF, USVMF | Ph. Eur. 11, USP-NF-2022, JP 16 | M. CATALANA & COPRIMA |
| QUETIAPINE FUMARATE | 111974-72-2 | Antipsychotic | CEP, EDMF, USDMF, KDMF | Ph. Eur. 11, USP-NF-2022 | M. CANTABRA |
| RABEPRAZOLE SODIUM | 117976-90-6 | Antiulcerative | CEP, EDMF, USDMF, ND | Ph. Eur. 11 | M. CATALANA |
| ROPIVACAINE HCL | 132112-35-7 | Local Anesthetic | USDMF | Ph. Eur. 11, USP-NF-2022 | BENECHIM |
| SECOBARBITAL SODIUM | 309-43-3 | Hypnotic - Sedative | ASMF (CTD) | BP 93 | CFB |
| SITAGLIPTIN HCL | 862156-92-1 | Antidiabetic | EDMF | in house | BENECHIM |
| SOTALOL HCL | 959-24-0 | Antianginal-Antihypertensive | CEP, EDMF, USDMF, ND | Ph. Eur. 11, USP-NF-2022 | M. CATALANA |
| SUMATRIPTAN BASE | 103628-46-2 | Antimigraine | USDMF | USP-NF-2022 | M. CATALANA |
| SUMATRIPTAN SUCCINATE | 103628-48-4 | Antimigraine | EDMF, USDMF, JDMF | Ph. Eur. 11, USP-NF-2022 | M. CATALANA |
| TAMOXIFEN CITRATE | 54965-24-1 | Antiestrogen - Antineoplastic (hormonal) | CEP, ASMF (CTD) | Ph. Eur., USD, Ph. Jap. | CFB |
| TERAZOSIN HCL DIHYDRATE | 70024-40-7 | Antihypertensive | CEP | Ph. Eur. | CFB |
| THIOPENTAL SODIUM & SODIUM CARBONATE STERILE | 71-73-8 | Anesthetic (intravenous) - Narcotic | CEP | Ph. Eur. | CFB |
| TRIMEBUTINE MALEATE | 34140-59-5 | Antispasmodic | CEP, EDMF, ND | Ph. Eur. 11, JP 16 | M. CATALANA & M. CANTABRA |
| VENLAFAXINE HCI | 99300-78-4 | Antidepressant | CEP, EDMF, USDMF | Ph. Eur. 11, USP-NF-2022 | M .CANTABRA |
| VILDAGLIPTIN | 274901-16-5 | Antidiabetic | DMF | Ph. Eur. 11 | BCN |
| XYLOMETAZOLINE HCL | 1218-35-5 | Decongestant – Rhinological therapeutic - Vasoconstrictor | CEP | Ph. Eur. | CFB |
| 4(6)-PROPYL-2- THIOURACIL | 51-52-5 | Antihyper thyroid | ASMF (CTD), DMF Type II | Ph. Eur., USP | CFB |
Productos en fase final de desarrollo
| Nombre del producto | CAS N° | Categoría terapéutica | Disponibilidad | Datos regulatorios | Farmacopea |
|---|---|---|---|---|---|
| EDOXABAN (**) | 1229194-11-9 | Oral anticoagulant | Validation batches | DMF | |
| EMPAGLIFLOZIN (**) | 864070-44-0 | Antidiabetic | Validation batches | DMF | |
| LEVOBUPIVACAINE HCL (**) | 27262-48-2 | Local Anesthetic-Antiarrhythmic | Validation batches | TP | |
| REMIMAZOLAM (**) | 308242-62-8 | Sedative | Laboratory batches | US-DMF | |
| RIVAROXABAN (**) | 366789-02-8 | Antibleeding agent | Validation batches | DMF | Ph. Eur. |
| SITAGLIPTIN HCL (**) | 862156-92-1 | Antidiabetic | Validation batches | DMF | |
| SITAGLIPTIN PHOSPHATE (**) | 654671-77-9 | Antidiabetic | Validation batches | DMF | USP / Ph. Eur. |
| VILDAGLIPTIN (**) | 274901-16-5 | Antidiabetic | Validation batches | DMF |
(**) Moehs está trabajando en este compuesto con fines experimentales, dirigidos exclusivamente a obtener autorizaciones de mercado de los medicamentos genéricos de nuestros clientes. No tenemos la intención de realizar ninguna actividad contra ninguna protección de patente válida, así como tampoco nos haremos cargo de acciones de terceros realizadas con el compuesto proporcionado y sin nuestro conocimiento contra esta protección.
Productos en etapa inicial de desarrollo
| Product Name | CAS N° | Therapeutic Category | Additional Information | DMF / TP |
|---|---|---|---|---|
| ABROCITINIB (**) | 1622902-68-4 | Atopic Dermatitis | Laboratory batches | TP |
| ACETYL-DL-LEUCINE | 99-15-0 | Vertigo treatment | Kilo-lab batches | |
| BLARCAMESINE HCL (**) | 195615-84-0 | Anti-Alzheimer, Anti-Redd Syndrome | Laboratory batches | |
| DARIDOREXANT (**) | 1792993-84-0 | Insomnia | Laboratory batches | |
| DEUCRAVACITINIB (**) | 1609392-27-9 | Psoriasis | Laboratory batches | |
| ELAGOLIX SODIUM (**) | 832720-36-2 | Uterine Fibroids, Endometriosis pain | Validation batches | TP |
| FEZOLINETANT(**) | 1629229-37-3 | Menopausal Vasomotor symptoms | Laboratory batches | |
| LASMIDITAN SUCCINATE | 439239-92-6 | Antimigraine | Kilo - Lab batches | DMF |
| LEMBOREXANT (**) | 1369764-02-2 | Insomnia treatment | Laboratory batches | TP |
| LEVOCLOPERASTINE FENDIZOATE | 220329-19-1 | CNS Antitussive | Laboratory batches | |
| LINZAGOLIX(**) | 935283-04-8 | Uterine Fibroids. Endometriosis | Laboratory batches | |
| MAVACAMTEN (**) | 1642288-47-8 | Hypertrophic Cardiomyopathy | Kilo-lab batches | DMF |
| RELUGOLIX (**) | 737789-87-6 | Advanced prostate cancer. Uterine Fibroids, endometriosis | Kilo-lab batches | DMF |
| SOTAGLIFLOZIN (**) | 1018899-04-1 | Antidiabetic Heart failure treatment | Laboratory batches | |
| TIRBANIBULIN (**) | 897016-82-9 | Actinic Keratosis | Kilo - Lab batches | DMF |
| ZAVEGEPANT (**) | 1414976-20-7 | Acute migraine | laboratory batches | |
| VERICIGUAT (**) | 1350653-20-1 | Heart Failure | Kilo - lab batches | DMF |
Nuevos Productos en evaluación
| Product Name | CAS N° | Brand Name | Therapeutic Category | Galenic Form |
|---|---|---|---|---|
| MAVACAMTEN (**) | 1642288-47-8 | Cardiovascular | capsules | |
| VERICIGUAT (**) | 1350653-20-1 | Antihypertensive | tablets |
